1. Home
  2. ULBI vs CTOR Comparison

ULBI vs CTOR Comparison

Compare ULBI & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • CTOR
  • Stock Information
  • Founded
  • ULBI 1990
  • CTOR 2021
  • Country
  • ULBI United States
  • CTOR United States
  • Employees
  • ULBI N/A
  • CTOR N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • CTOR
  • Sector
  • ULBI Miscellaneous
  • CTOR
  • Exchange
  • ULBI Nasdaq
  • CTOR NYSE
  • Market Cap
  • ULBI 98.1M
  • CTOR 89.9M
  • IPO Year
  • ULBI 1992
  • CTOR N/A
  • Fundamental
  • Price
  • ULBI $4.28
  • CTOR $0.67
  • Analyst Decision
  • ULBI Strong Buy
  • CTOR Strong Buy
  • Analyst Count
  • ULBI 1
  • CTOR 2
  • Target Price
  • ULBI $14.00
  • CTOR $4.50
  • AVG Volume (30 Days)
  • ULBI 77.2K
  • CTOR 3.9M
  • Earning Date
  • ULBI 04-28-2025
  • CTOR 05-21-2025
  • Dividend Yield
  • ULBI N/A
  • CTOR N/A
  • EPS Growth
  • ULBI N/A
  • CTOR N/A
  • EPS
  • ULBI 0.38
  • CTOR N/A
  • Revenue
  • ULBI $164,456,000.00
  • CTOR N/A
  • Revenue This Year
  • ULBI $35.52
  • CTOR N/A
  • Revenue Next Year
  • ULBI N/A
  • CTOR N/A
  • P/E Ratio
  • ULBI $11.21
  • CTOR N/A
  • Revenue Growth
  • ULBI 3.66
  • CTOR N/A
  • 52 Week Low
  • ULBI $4.14
  • CTOR $0.55
  • 52 Week High
  • ULBI $13.39
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 32.50
  • CTOR N/A
  • Support Level
  • ULBI $4.14
  • CTOR N/A
  • Resistance Level
  • ULBI $4.87
  • CTOR N/A
  • Average True Range (ATR)
  • ULBI 0.39
  • CTOR 0.00
  • MACD
  • ULBI -0.00
  • CTOR 0.00
  • Stochastic Oscillator
  • ULBI 10.29
  • CTOR 0.00

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: